Dentistry goes beyond providing excellent oral care to patients. It also requires an accurate record of the care that was delivered, making CDT codes an essential part of dentists’ everyday business. 2022 code changes include: 16 new codes, 14 revisions, 6 deletions, and the 8 codes adopted in March 2021 regarding vaccine administration and molecular testing for a public health related pathogen. CDT 2022 contains new codes for: Previsit patient screenings; Fabricating, adjusting and repairing sleep apnea appliances; Intracoronal and extracoronal splints; Immediate partial dentures; Rebasing hybrid prostheses; Removal of temporary anchorage devices. Also includes alphabetic and numeric indices and ICD 10 CM codes related to dental procedures. CDT codes are developed by the ADA and are the only HIPAA recognized code set for dentistry. Includes app and ebook access.

Identifies thousands of prescription drugs, and provides information on ingredients, purpose, usage, precautions, side effects, and dosages.

Contains full FDA-approved drug label information, including warnings and precautions, drug interactions, and hundreds of color pill images, as well as dosages, clinical-trials, side effects, and safety.

A best-selling medical guide that includes essential information used in everyday medical practice. Badge size vertical format.

Identifies thousands of prescription drugs, and provides information on ingredients, purpose, usage, precautions, side effects, and dosages.

Designed as a true introduction to the subject, Essentials of Pharmacoeconomics: Health Economics and Outcomes Research, ThirdEdition includes information on fundamental topics, defines terminology, and provides examples for evaluating published research, making it perfect for any pharmacy student or practitioner new to the topic. This updated edition provides the critical foundations of knowledge for measuring costs and health-related quality-of-life (HRQoL) and evaluating the four types of studies (CMA, CEA, CUA, and CBA); it also explains Markov and Budget Impact Analysis modeling, and discusses the advantages and disadvantages of using retrospective databases and real-world data (RWD). Additionally, the text summarizes the use of pharmacoeconomic evaluations by decision makers outside of the United States and the extent to which pharmacoeconomic data are used to make decisions in the United States, includes barriers to its use, and discusses future issues. All of this information is designed to ensure preparedness to improve clinical and humanistic outcomes based on available resources.